Terrence J. Bradley, M.D.
- Assistant Professor
Dr. Bradley primary career interests are in early-phase clinical research in acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). These disorders are very heterogeneous, and patients with these diseases are faced with poor prognosis. More optimal therapies are in need, particularly in acute myeloid leukemia (excluding APL), where conventional and standard treatments have largely not seen a significant change in over forty years. He completed fellowship training at JMH and SCCC, where under the direction of Ronan Swords and Justin Watts, he was able to gain nearly three years of experience in clinical research, particularly in phase 1 trials. As he is currently working on an IIT and is slated to PI on industry studies in his first year as faculty, Dr. Bradley goal is to apply for a career development or K award during my second year as faculty.